PRISTINAMYCIN: 783 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
783
Total FAERS Reports
24 (3.1%)
Deaths Reported
532
Hospitalizations
783
As Primary/Secondary Suspect
72
Life-Threatening
First Report: 20010101 · Latest Report: 20250825
What Are the Most Common PRISTINAMYCIN Side Effects?
#1 Most Reported
Acute kidney injury
112 reports (14.3%)
#2 Most Reported
Rash maculo-papular
52 reports (6.6%)
#3 Most Reported
Hepatocellular injury
41 reports (5.2%)
All PRISTINAMYCIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Acute kidney injury | 112 | 14.3% | 4 | 55 |
| Rash maculo-papular | 52 | 6.6% | 1 | 47 |
| Drug reaction with eosinophilia and systemic symptoms | 41 | 5.2% | 0 | 35 |
| Hepatocellular injury | 41 | 5.2% | 0 | 28 |
| Acute generalised exanthematous pustulosis | 40 | 5.1% | 0 | 39 |
| Lactic acidosis | 39 | 5.0% | 0 | 10 |
| Vomiting | 39 | 5.0% | 0 | 23 |
| Cholestasis | 37 | 4.7% | 0 | 23 |
| Arthralgia | 32 | 4.1% | 0 | 21 |
| Condition aggravated | 32 | 4.1% | 0 | 20 |
| Diarrhoea | 32 | 4.1% | 0 | 16 |
| Pruritus | 31 | 4.0% | 1 | 27 |
| Hyperkalaemia | 29 | 3.7% | 1 | 12 |
| Pancreatitis acute | 29 | 3.7% | 1 | 28 |
| Erythema | 24 | 3.1% | 0 | 19 |
| Hyponatraemia | 24 | 3.1% | 1 | 24 |
| Eosinophilia | 21 | 2.7% | 0 | 18 |
| Rash | 21 | 2.7% | 2 | 13 |
| Malaise | 19 | 2.4% | 1 | 8 |
| Pyrexia | 19 | 2.4% | 0 | 17 |
Who Reports PRISTINAMYCIN Side Effects? Age & Gender Data
Gender: 59.5% female, 40.5% male. Average age: 62.9 years. Most reports from: FR. View detailed demographics →
Is PRISTINAMYCIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 1 |
| 2008 | 2 | 1 | 2 |
| 2009 | 4 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 4 | 0 | 3 |
| 2013 | 8 | 0 | 7 |
| 2014 | 31 | 5 | 19 |
| 2015 | 22 | 1 | 20 |
| 2016 | 39 | 3 | 29 |
| 2017 | 58 | 2 | 42 |
| 2018 | 123 | 2 | 94 |
| 2019 | 74 | 0 | 54 |
| 2020 | 77 | 0 | 50 |
| 2021 | 69 | 2 | 47 |
| 2022 | 34 | 5 | 22 |
| 2023 | 50 | 0 | 35 |
| 2024 | 68 | 2 | 46 |
| 2025 | 20 | 0 | 16 |
What Is PRISTINAMYCIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 101 |
| Bronchitis | 68 |
| Erysipelas | 59 |
| Infection | 57 |
| Paronychia | 33 |
| Sinusitis | 27 |
| Antibiotic therapy | 21 |
| Dermo-hypodermitis | 20 |
| Lung disorder | 20 |
| Urinary tract infection | 20 |
PRISTINAMYCIN vs Alternatives: Which Is Safer?
PRISTINAMYCIN vs PRISTIQ
PRISTINAMYCIN vs PRIVIGEN
PRISTINAMYCIN vs PROAIR HFA
PRISTINAMYCIN vs PROBIOTICS NOS
PRISTINAMYCIN vs PROBUCOL
PRISTINAMYCIN vs PROCAINAMIDE
PRISTINAMYCIN vs PROCAINE
PRISTINAMYCIN vs PROCARBAZINE
PRISTINAMYCIN vs PROCHLORPERAZINE
PRISTINAMYCIN vs PROCHLORPERAZINE EDISYLATE
Official FDA Label for PRISTINAMYCIN
Official prescribing information from the FDA-approved drug label.